Holen Sie sich die Stockscreener-App
15.78
3.10%
0.45
Schlusskurs vom Vortag:
$15.33
Offen:
$15.34
24-Stunden-Volumen:
348.37K
Relative Volume:
0.26
Marktkapitalisierung:
$1.21B
Einnahmen:
$54.55M
Nettoeinkommen (Verlust:
$-193.57M
KGV:
-5.4602
EPS:
-2.89
Netto-Cashflow:
$-181.86M
1W Leistung:
+23.48%
1M Leistung:
+51.68%
6M Leistung:
+61.61%
1J Leistung:
-29.35%
1-Tages-Spanne:
$15.25
$16.28
1-Wochen-Bereich:
$12.43
$16.28
52-Wochen-Spanne:
$8.18
$23.00
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Firmenname
Nurix Therapeutics Inc
Sektor
Branche
Telefon
(415) 660-5320
Adresse
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Vergleichen Sie NRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
15.78 | 1.55B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.08 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.96 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.59 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.80 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
197.94 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | Jefferies | Buy |
| 2024-09-06 | Fortgesetzt | Robert W. Baird | Outperform |
| 2024-07-31 | Eingeleitet | Truist | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-09 | Eingeleitet | Barclays | Overweight |
| 2023-02-28 | Eingeleitet | Oppenheimer | Outperform |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-12-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-04-30 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2020-11-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
How analysts rate Nurix Therapeutics Inc. stock todayQuarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 10.4%Should You Buy? - MarketBeat
How sustainable is Nurix Therapeutics Inc. stock dividend payoutJuly 2025 Volume & Community Consensus Picks - newser.com
Patient Square Capital LP Has $4.70 Million Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Key metrics from Nurix Therapeutics Inc.’s quarterly dataWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Will Nurix Therapeutics Inc. stock outperform Nasdaq indexTake Profit & Verified Momentum Watchlists - newser.com
How moving averages guide Nurix Therapeutics Inc. tradingTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Why Nurix Therapeutics Inc. stock is a must watch in 20252025 Market Overview & Daily Price Action Insights - newser.com
Can Nurix Therapeutics Inc. recover in the next quarter2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
What to expect from Nurix Therapeutics Inc. in the next 30 daysBull Run & Fast Momentum Entry Tips - newser.com
Candriam S.C.A. Sells 326,547 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Inc. stock daily chart insights2025 Institutional Moves & Fast Exit and Entry Trade Guides - newser.com
Signal strength of Nurix Therapeutics Inc. stock in tech scannersMarket Activity Summary & Safe Entry Point Alerts - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.Quarterly Trade Review & Reliable Breakout Forecasts - newser.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
Visual trend scoring systems applied to Nurix Therapeutics Inc.2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Will Nurix Therapeutics Inc. stock sustain high P E ratiosWeekly Investment Report & Fast Moving Trade Plans - newser.com
Is Nurix Therapeutics Inc. stock a buy for dividend growthBond Market & Capital Protection Trading Alerts - newser.com
Is Nurix Therapeutics Inc. stock ready for breakoutEarnings Beat & Weekly High Potential Stock Alerts - newser.com
Analyzing Nurix Therapeutics Inc. with risk reward ratio chartsJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of Nurix Therapeutics Inc. stockQuarterly Portfolio Report & Smart Swing Trading Techniques - newser.com
What analysts say about Nurix Therapeutics Inc stockAnalyst Downgrades & Small Budget Capital Gain - earlytimes.in
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):